Article

Multiomics machine learning identifies inflammation molecular pathways in prodromal Alzheimer’s Disease

2023-03-06

Abstract excerpt

Mild Cognitive Impairment (MCI) is a phase that can precede Alzheimer’s Disease (AD). To better understand the molecular mechanisms underlying conversion from MCI to AD, we applied a battery of machine learning algorithms on 800 samples from the EMIF-AD MBD study. The cohort comprised participants diagnosed as 230 normal cognition (NC), 386 MCI (with longitudinal data on AD conversion or remaining stable) and 184...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b38cc2c6-3278-5823-8706-bfbb18c0de22
DOI: 10.1101/2023.03.02.23286674

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multiomics machine learning identifies inflammation molecular pathways in prodromal Alzheimer’s DiseaseDOI 10.1101/2023.03.02.23286674Read

CSF metabolites associated with biomarkers of Alzheimer’s disease pathologySemantic proximity Read

Brain cross-omics integration in Alzheimer’s diseaseSemantic proximity Read

An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer’s diseaseSemantic proximity Read

Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s diseaseSemantic proximity Read

Multiomics profiling of human plasma and CSF reveals ATN derived networks and highlights causal links in Alzheimer’s diseaseSemantic proximity Read

Identification and Validation of New Molecular Subtypes within the Early and Late Mild Cognitive Impairment Stages of Alzheimer’s DiseaseSemantic proximity Read

Predicting Alzheimer’s Disease with Multi-Omic Data: A Systematic ReviewSemantic proximity Read

Multi-Omics Modelling of Plasma pTau181, GFAP, and Metabolic Features Enables Risk Stratification in Prodromal Alzheimer’s DiseaseSemantic proximity Read

Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer’s diseaseSemantic proximity Read

CSF metabolites associated with biomarkers of Alzheimer’s disease pathologySemantic proximity Read

A leakage-controlled multi-compartment benchmark of fluid biomarkers for predicting mild cognitive impairment to Alzheimer’s disease conversion: plasma, CSF, and high-plex omics in a single cohortSemantic proximity Read

Untargeted metabolomics reveals sugar and homocysteine dysregulations in prodromal ADSemantic proximity Read